Global Transcranial Magnetic Stimulators Market Size By Type (STMS, PTMS), By Application (Depression, Tinnitus), By Region, And Segment Forecasts, 2023 to 2032

The Global Transcranial Magnetic Stimulators Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.7 billion by 2031, growing at a CAGR of 12.1% during the forecast period from 2023 to 2031. Transcranial Magnetic Stimulators (TMS) are non-invasive devices used for brain stimulation, increasingly adopted in treating neurological and psychiatric disorders such as depression, anxiety, Parkinson’s disease, and chronic pain. The market's expansion is driven by the growing prevalence of these disorders, rising awareness of non-invasive neuromodulation techniques, and the increasing preference for drug-free treatment alternatives.

Drivers:

1. Rising Prevalence of Neurological Disorders:

The increasing incidence of neurological and psychiatric conditions, particularly major depressive disorder (MDD), is a key growth driver. TMS has been recognized as an effective, FDA-approved treatment for patients unresponsive to conventional therapies.

2. Technological Advancements in Neuromodulation:

Innovations in coil design, navigational imaging integration, and real-time monitoring capabilities are enhancing the safety, efficacy, and personalization of TMS therapies.

3. Growing Demand for Non-Invasive Treatments:

As patients and healthcare providers seek alternatives to pharmacological treatments, especially for long-term management, the demand for non-invasive and side-effect-free solutions like TMS is rising.

Restraints:

1. High Cost of Equipment and Treatment:

The initial investment in TMS devices and the recurring costs of therapy sessions can be prohibitively expensive, particularly in regions with limited healthcare reimbursement frameworks.

2. Limited Skilled Professionals:

The effective administration of TMS requires trained neurotechnicians and clinicians, and the shortage of skilled personnel poses a significant barrier to widespread adoption, especially in low-income and rural settings.

Opportunity:

1. Expansion into Emerging Markets:

Growing healthcare infrastructure and awareness campaigns in Asia-Pacific, Latin America, and the Middle East present new opportunities for market players to expand their footprint.

2. Integration with Digital Health Technologies:

Combining TMS systems with AI, remote monitoring, and telemedicine platforms offers potential to personalize treatment, monitor real-time outcomes, and expand accessibility.

Market by System Type Insights:

By system type, the Repetitive TMS (rTMS) segment held the largest market share in 2023. rTMS is widely used in clinical settings due to its robust evidence base, particularly in treating depression and chronic pain. The Deep TMS segment is expected to witness the fastest growth rate owing to its ability to stimulate deeper brain regions, offering improved outcomes in treatment-resistant cases.

Market by End-use Insights:

In terms of end use, Hospitals & Clinics accounted for the majority of the market in 2023. The availability of advanced medical infrastructure and specialized personnel supports higher adoption in this setting. However, the Home Care Settings segment is gaining traction due to portable and wearable TMS devices being introduced, supported by increasing telemedicine utilization.

Market by Regional Insights:

North America dominated the global market in 2023, attributed to robust healthcare infrastructure, high awareness, favorable reimbursement policies, and the early adoption of TMS technologies. The Asia-Pacific region is projected to register the highest CAGR during the forecast period, fueled by expanding mental health services, increased healthcare spending, and supportive governmental initiatives.

Competitive Scenario:

Leading players in the Global Transcranial Magnetic Stimulators Market include:

BrainsWay Ltd.

Magstim

Neuronetics Inc.

MagVenture A/S

Neurosoft

Yiruide Co., Ltd.

eNeura Inc.

CloudTMS

Nexstim Plc

Key strategies adopted by these companies include product innovation, regional expansion, and strategic collaborations with research institutions and hospitals. Notable developments include:

2023: BrainsWay launched an upgraded Deep TMS system with AI-based session optimization algorithms.

2024: Magstim entered into a partnership with a U.S. telepsychiatry provider to deliver remote-controlled TMS treatments.

2025: Neuronetics announced clinical trial results showing superior outcomes for its next-gen TMS device in treating postpartum depression.

Scope of Work – Global Transcranial Magnetic Stimulators Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.7 billion

CAGR (2023–2031) 12.1%

Market Segments By System Type (rTMS, Deep TMS), By End-use (Hospitals & Clinics, Home Care Settings)

Growth Drivers Rising neurological disorder cases, technological innovation, demand for non-invasive treatments

Opportunities Expansion in emerging markets, integration with digital health platforms

Key Market Developments:

BrainsWay Ltd. (2023): Released a Deep TMS coil targeting anxiety-specific brain regions.

MagVenture A/S (2024): Introduced a silent TMS solution designed to enhance patient comfort.

Neuronetics Inc. (2025): Collaborated with mental health organizations to broaden access to TMS in rural healthcare facilities.

FAQs:

1) What is the current market size of the Global Transcranial Magnetic Stimulators Market?

The market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Transcranial Magnetic Stimulators Market?

The primary driver is the rising prevalence of neurological disorders and the growing preference for non-invasive treatment methods.

3) Which is the largest region during the forecast period in the Global Transcranial Magnetic Stimulators Market?

North America is the leading region due to advanced healthcare systems and early adoption of TMS technology.

4) Which segment accounted for the largest market share in Global Transcranial Magnetic Stimulators Market?

The Repetitive TMS (rTMS) segment held the largest market share in 2023.

5) Who are the key market players in the Global Transcranial Magnetic Stimulators Market?

Key players include BrainsWay Ltd., Magstim, Neuronetics Inc., MagVenture A/S, and Neurosoft.